Thrombosis risk stratification: Difference between revisions
No edit summary |
No edit summary |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombosis}} | {{Thrombosis}} | ||
{{CMG}} {{AE}} {{VE}} | |||
==Overview== | |||
Presence of a [[thrombophilia|risk factor for thrombosis]] has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor. | |||
== | ==Risk Factors== | ||
The Thrombosis formation is a phenomenon that can be elicited by various conditions, all of which take effect by means of mechanisms of [[Virchow's triad]]. Blood stasis, endothelial defect or [[hypercoagulability]]. | |||
*General | |||
* | |||
**Older age | **Older age | ||
**Female gender | **Female gender | ||
| Line 17: | Line 17: | ||
**Immobilization | **Immobilization | ||
* | *Medical | ||
**Surgery | **Surgery | ||
**[[Congestive heart failure and thrombosis|Heart failure]] | **[[Congestive heart failure and thrombosis|Heart failure]] | ||
| Line 31: | Line 31: | ||
**[[Disseminated intravascular coagulation]] | **[[Disseminated intravascular coagulation]] | ||
* | *Familial | ||
**[[Antithrombin|Antithrombin III deficiency]] | **[[Antithrombin|Antithrombin III deficiency]] | ||
**[[Protein C deficiency]]/[[Protein S deficiency]] | **[[Protein C deficiency]]/[[Protein S deficiency]] | ||
| Line 38: | Line 38: | ||
**Hypoplasminogenemia | **Hypoplasminogenemia | ||
**Familial homocysteinemia | **Familial homocysteinemia | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 09:05, 29 January 2019
|
Thrombosis Microchapters |
|
Site of Thrombosis |
|---|
|
Differentiating Thrombosis from other Diseases |
|
Diagnosis |
|
Treatment |
|
Thrombosis risk stratification On the Web |
|
Risk calculators and risk factors for Thrombosis risk stratification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vahid Eidkhani, M.D.
Overview
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.
Risk Factors
The Thrombosis formation is a phenomenon that can be elicited by various conditions, all of which take effect by means of mechanisms of Virchow's triad. Blood stasis, endothelial defect or hypercoagulability.
- Medical
- Familial
- Antithrombin III deficiency
- Protein C deficiency/Protein S deficiency
- APC resistance (Factor V Leiden)
- Dysfibrogenemia
- Hypoplasminogenemia
- Familial homocysteinemia